MedTrace Logo

Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

NCT03743155 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-11-16

No results posted yet for this study

Summary

Phase II not controlled, open-label, prospective, single center clinical trial

Conditions

  • Xerostomia Due to Radiotherapy

Interventions

BIOLOGICAL

mesenchymal cells

Autologous bone marrow aspiration is used as a cellular source to obtain MSVs and is subjected to the protocolized anticoagulant procedure. After checking the perfect condition of the shipment and the correct completion of the documentation that accompanies it, the processing of the bone marrow will be carried out. The processing of the bone marrow will be done in the Cell Therapy Unit of the IBGM under NCF, within 24 hours of the completion of the aspiration

Sponsors & Collaborators

  • Institut de Terapia Regenerativa Tissular

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-15
Primary Completion
2019-05-30
Completion
2021-05-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03743155 on ClinicalTrials.gov